P&G’s (PG) $3.8B Wellness Deal Collides With a Costly Outlook
Procter & Gamble (PG) is acquiring Thorne, a science-backed health and wellness brand, for $3.8 billion in cash. This deal expands P&G's presence in the wellness category, but it comes amidst a challenging fiscal 2027 outlook, which includes approximately $1 billion in new cost headwinds from commodity, energy, and transportation expenses, leading to projected low single-digit core EPS growth. Investors are balancing the long-term growth potential of the wellness acquisition against the immediate pressure of rising costs.
Why it matters
Attributed market update with source link for portfolio context.